共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R032738-25mg | 25mg | 5~7个工作日 |
LY2228820 LY2228820 |
99% |
|
|
罗恩 | R032738-50mg | 50mg | 5~7个工作日 |
LY2228820 LY2228820 |
99% |
|
|
罗恩 | R032738-5mg | 5mg | 5~7个工作日 |
LY2228820 LY2228820 |
99% |
|
|
罗恩 | R032738-10mg | 10mg | 5~7个工作日 |
LY2228820 LY2228820 |
99% |
|
|
阿拉丁 | L127430-5mg | 5mg | 现货 |
LY2228820,新型有效的p38 MAPK抑制剂 LY2228820 |
≥98% |
|
|
阿拉丁 | L127430-25mg | 25mg | 现货 |
LY2228820,新型有效的p38 MAPK抑制剂 LY2228820 |
≥98% |
|
|
阿拉丁 | L127430-50mg | 50mg | 现货 |
LY2228820,新型有效的p38 MAPK抑制剂 LY2228820 |
≥98% |
|
|
阿拉丁 | R408560-1ml | 1ml | 现货 |
LY2228820 Ralimetinib (LY2228820) dime... |
10mM in Water |
|
|
凯为 | JZ00GV47-50mg | 50mg | 期货,请咨询 |
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5... LY2228820 |
98% |
|
|
凯为 | JZ00GV47-100mg | 100mg | 期货,请咨询 |
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5... LY2228820 |
98% |
|
|
毕得 | BD306011-50mg | 50mg | 现货 |
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5... 5-(2-(tert-Butyl)-4-(4-fluor... |
98% |
|
|
毕得 | BD306011-100mg | 100mg | 现货 |
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5... 5-(2-(tert-Butyl)-4-(4-fluor... |
98% |
|
|
Matrix | MA145185-10mg | 10mg | 3-4周 |
5-(2-tert-Butyl-5-(4-fluorop... 5-(2-tert-Butyl-5-(4-fluorop... |
95% | 咨询 | 请联系客服购买! |
Matrix | MA145185-50mg | 50mg | 3-4周 |
5-(2-tert-Butyl-5-(4-fluorop... 5-(2-tert-Butyl-5-(4-fluorop... |
95% | 咨询 | 请联系客服购买! |
源叶 | S81027-5mg | 5mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98% |
|
|
源叶 | S81027-10mg | 10mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98% |
|
|
源叶 | S81027-25mg | 25mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98% |
|
|
源叶 | S81027-100mg | 100mg | 期货,请咨询 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98% |
|
|
源叶 | T28960-1ml | 1ml | 期货,请咨询 |
Ralimetinib dimesylate Ralimetinib dimesylate |
10mM in DMSO |
|
|
Target Mol | T6047-1mg | 1mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-2mg | 2mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-5mg | 5mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-10mg | 10mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-25mg | 25mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-50mg | 50mg | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-100mg | 100mg | 期货,请咨询 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Target Mol | T6047-1mL | 1mL | 现货 |
化合物 Ralimetinib dimesylate Ralimetinib dimesylate |
99.38% |
|
|
Combi | QW-4235-100mg | 100mg | 请咨询 |
Ly2228820 Ly2228820 |
95% | 咨询 | 请联系客服购买! |
Am | A413122-25mg | 25mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
Am | A413122-10mg | 10mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
Am | A413122-5mg | 5mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
Am | A413122-50mg | 50mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
Am | A413122-100mg | 100mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
Am | A413122-1mg | 1mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
98+% |
|
|
MCE | HY-13241-100mg | 100mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|
MCE | HY-13241-50mg | 50mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|
MCE | HY-13241-10mg | 10mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|
MCE | HY-13241-10mM*1mL | 10mM*1mL | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|
MCE | HY-13241-5mg | 5mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|
MCE | HY-13241-1mg | 1mg | 现货 |
Ralimetinib dimesylate Ralimetinib dimesylate |
99.91% |
|
|